Day: April 6, 2020

Copenhagen, 6 April 2020                                   In connection with fundamental changes to the company’s work, focus and tasks ahead, the Board proposes changes to the composition of the Board of Directors for election at the Annual General Assembly on 30 April 2020.The Board proposes re-election of Jesper Teddy Lok, and in addition proposes election of Ole Steffensen and Martin Thaysen as new Members of the Board. Martin Thaysen will continue daily management of the company.Current Chairman, Henning Kruse Petersen, and current Vice Chairman, Preben Sunke, will not seek re-election.Under the assumption that above candidates are elected for the Board, it is the intention to elect Jesper Teddy Lok as Chairman for the Board of Directors after the Annual General Meeting.Further information about the candidates for the Board, will...

København, 6. april 2020                                      I forbindelse med ændringer i selskabets virke, fokus og arbejdsopgaver, foreslås ændringer til sammensætningen af bestyrelsen til valg på årets generalforsamling den 30. april 2020.Bestyrelsen foreslår genvalg af Jesper Teddy Lok, og foreslår derudover valg af Ole Steffensen og Martin Thaysen som nye medlemmer af bestyrelsen. Martin Thaysen fortsætter med at lede den daglige drift.Nuværende formand, Henning Kruse Petersen, og nuværende næstformand, Preben Sunke, vil således ikke genopstille.Under forudsætning af valget af ovennævnte kandidater, er det bestyrelsens intention at konstituere sig med Jesper Teddy Lok som formand for bestyrelsen efter generalforsamlingen.Yderligere information om kandidaterne til bestyrelsen vil kunne findes i indkaldelsen til generalforsamlingen,...

– First Non-Statin, LDL-C Lowering Combination Medicine Ever Approved in Europe –– NUSTENDI Is Approved for Patients Who Require Additional LDL-Cholesterol Lowering on a Background Statin, Other Lipid-Lowering Therapies, or Considered Statin Intolerant –– Daiichi Sankyo Europe to Lead EU Commercialization, Cardiovascular Sales Organization Exceeds 1,000 Professionals –– Esperion to Receive $150 Million Milestone Payment Upon First Commercial Sale –ANN ARBOR, Mich., April 06, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) announced today the European Commission approved the NUSTENDI™ (bempedoic acid and ezetimibe) tablet, an oral, once-daily, non-statin LDL-cholesterol (LDL-C) lowering medicine for hypercholesterolemia and dyslipidemia in Europe. NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary...

ANN ARBOR, Mich., April 06, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), the leading developer of spider silk based fibers, announces that Kim Thompson, the Company’s CEO and Founder, has accepted an invitation to speak at this year’s SynBio Markets conference to be held in Amsterdam, Netherlands beginning November 3rd.SynBio Markets focus is synthetic biology solutions to commercial and sustainability challenges.  The international conference is designed to showcase the most innovative synthetic biology companies.“We are delighted to be welcoming Mr. Thompson to the conference and have such a leader in innovation as Kraig Biocraft Laboratories joining the speaker lineup in Amsterdam. Building on the successful launch event in 2019 we will once again be connecting synbio investors, academics and innovators...

SALT LAKE CITY, April 06, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it has received reimbursement and launched the BRACAnalysis® Diagnostic System (i.e., “BRACAnalysis”) in Japan to help physicians determine which people affected with breast and ovarian cancer have Hereditary Breast and Ovarian Cancer (HBOC) syndrome and qualify for additional diagnostic and medical management.  BRACAnalysis previously was approved by Japan’s Ministry of Health, Labour and Welfare (MHLW) in November 2019 for this indication.“We are excited that the BRACAnalysis Diagnostic System is now available to assess HBOC risk in people with breast and ovarian cancer,” said Seigo Nakamura, M.D., Ph.D., Professor and Chairman, Department of Surgery, Division of Breast...

– First Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine Approved in Europe in Almost Two Decades for Indicated Patients –– NILEMDO Is Approved for Patients Who Require Additional LDL-Cholesterol Lowering on a Background Statin, Other Lipid-Lowering Therapies, or Considered Statin-Intolerant –– Pharmacology Section Highlights NILEMDO Reduced HbA1c on Average of 0.2% Versus Placebo in Patients with Diabetes –– Daiichi Sankyo Europe to Lead EU Commercialization, Cardiovascular Sales Organization Exceeds 1,000 Professionals –– Esperion to Receive $150 Million Milestone Payment Upon First Commercial Sale –ANN ARBOR, Mich., April 06, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) announced today the European Commission approved the NILEMDO™ (bempedoic acid) tablet, an oral, once-daily, non-statin LDL-cholesterol (LDL-C)...

VANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY) (“Search” or the “Company”) is pleased to report assay results from FOX MEADOW, its third major mineralized zone in it’s Critical Rare Earth Element (“CREE”) District in SE Labrador. Trenching/channelling (6 new channels), mapping/prospecting and a UAV Magnetometer Survey indicate that the surface expression of this mineralized zone is up to 124m wide and 650m long. This surface expression is significantly larger than those over the related FOXTROT and DEEP FOX Resources. The mineralization is similarly hosted by peralkaline volcanic rocks and contains similar grades of the REE magnet materials (Nd, Pr, Tb and Dy); Zr and Hf also occur in significant concentrations. HIGHLIGHTS OF FOX MEADOW 2019 CHANNEL PROGRAMFOX MEADOW (all true widths)...

CAMBRIDGE, Mass., April 06, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Richard Levy, M.D., has been appointed to its Board of Directors.Dr. Levy has nearly 30 years of experience in the pharmaceutical and biotechnology sectors, where he held senior clinical development positions at Incyte, Celgene, DuPont Pharmaceuticals, and Sandoz / Novartis. He served as Executive Vice President and Chief Drug Development and Medical Officer at Incyte, where from 2003 to 2016 he was responsible for the expansion of the clinical development portfolio in oncology and inflammation. Dr. Levy currently serves on the boards of Madrigal Pharmaceuticals, Kodiak Sciences, Kiniksa...

DENVER, April 06, 2020 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the thirteen week period ended February 29, 2020. The Company completed the acquisition of Quest Nutrition, LLC (“Quest”) on November 7, 2019. The Company’s second quarter results include thirteen weeks of Quest results and about 16 weeks for the year-to-date period. Additionally, note that the Company’s reference to “legacy Atkins” in this press release encompasses Simply Goods Foods’ business excluding Quest.“Simply Good Foods second quarter results exceeded our expectations with strong performance from both the legacy Atkins and Quest brands,” said Joseph E. Scalzo, President and...

NASHVILLE, Tenn., April 06, 2020 (GLOBE NEWSWIRE) — SmileDirectClub, the industry pioneer and first direct-to-consumer medtech platform for teeth straightening, today announced it is opening its proprietary teledentistry platform to any licensed dentist or orthodontist in the United States to help them communicate with their patients while their physical offices are closed or limited to emergency procedures. As the American Dental Association and state dental boards and associations mandate the postponement of all non-essential dentist appointments and procedures amid the COVID-19 pandemic, the opening of the SmileDirectClub teledentistry platform will allow dentists and orthodontists to communicate with and treat their patients remotely. SmileDirectClub is making available its telehealth app with video and live chat capabilities...